ABBV-CLS-484, an Orally Bioavailable, Dual PTPN1/PTPN2 Phosphatase Inhibitor with Antitumor Activity (Synfacts, 2023)
Keywords: phosphatase inhibitor; phosphate isostere; immunomodulatory; anti-tumor agent